Citations

Clear

959 citation(s) found for "Service, F J".

Results of Arthroscopic Capsulolabral Repair: Bankart Lesion Versus Anterior Labroligamentous Periosteal Sleeve Avulsion Lesion
Ozbaydar, Mehmet, Elhassan, Bassem T. , Diller, David, Massimini, Daniel F., Higgins, Laurence D. , Warner, Jon J.P.

Mayo Clinic

Arthroscopy | November 10, 2008 | Volume: 24 | Issue: 11 | Pages: 1277-1283

10.1016/j.arthro.2008.01.017 | PMID 18971059 Get It

Purpose The purpose of this study was to evaluate the results of arthroscopic capsulolabral repair for traumatic anterior shoulder instability and to compare the outcome in patients who have Bankart lesions versus those with anterior labroligamentous periosteal sleeve avulsion (ALPSA) lesions. Methods This study included 99 patients (93 shoulders), 72 male and 17 female, with a mean age of 32 years, who underwent arthroscopic Bankart repair for traumatic, recurrent anterior shoulder instability, by use of suture anchors. In 67 shoulders (72%) a discrete Bankart lesion was repaired, and in 26 shoulders (28%) an ALPSA lesion was repaired. The 2 groups were analyzed with regard to the number of preoperative dislocations and number of postoperative recurrences. Results At a mean follow‐up of 47 months (range, 24 to 98 months), recurrence of instability was documented in 10 shoulders (10.7%). Of the shoulders, 5 had Bankart lesions (7.4%) and 5 had ALPSA lesions (19.2%) ( P = .0501). The mean number of dislocations or subluxations before the index surgery was significantly higher in the ALPSA group (mean, 12.3 [range, 2 to 57]) than in the Bankart group (mean, 4.9 [range, 2 to 24]) ( P < .05). However, there were no significant differences in the number of anchors used, incidence of minor glenoid erosion, or incidence of bony Bankart lesions between the groups ( P > .05 for all). Conclusions Patients with ALPSA lesions present with a higher number of recurrent dislocations than those with discrete Bankart lesions. In addition, the failure rate after arthroscopic capsulolabral repair is higher in the ALPSA group than in the Bankart group. Level of Evidence Level IV, therapeutic case series.
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis
Ford, Alexander C. , Zanten, S. J. O. Veldhuyzen van, Rodgers, Christopher, Talley, N. J., Vakil, Nimish , Moayyedi, Paul , Ford, Alexander C , Moayyedi, Paul

Mayo Clinic

Gut | August 1, 2008 | Volume: 57 | Issue: 11 | Pages: 1545-1553

10.1136/gut.2008.159723 | PMID 18676420 Get It

Objective: Colorectal cancer is the second most common cause of cancer death in Europe and North America. Alarm features are used to prioritise access to urgent investigation, but there is little information concerning their utility in the diagnosis of colorectal cancer. Methods: A systematic review and meta-analysis of the published literature was carried out to assess the diagnostic accuracy of alarm features in predicting colorectal cancer. Primary or secondary care-based studies in unselected cohorts of adult patients with lower gastrointestinal symptoms were identified by searching MEDLINE, EMBASE and CINAHL (up to October 2007). The main outcome measures were accuracy of alarm features or statistical models in predicting the presence of colorectal cancer after investigation. Data were pooled to estimate sensitivity, specificity, and positive and negative likelihood ratios. The quality of the included studies was assessed according to predefined criteria. Results: Of 11 169 studies identified, 205 were retrieved for evaluation. Fifteen studies were eligible for inclusion, evaluating 19 443 patients, with a pooled prevalence of colorectal carcinoma of 6% (95% CI 5% to 8%). Pooled sensitivity of alarm features was poor (5% to 64%) but specificity was >95% for dark red rectal bleeding and abdominal mass, suggesting that the presence of either rules the diagnosis of colorectal cancer in. Statistical models had a sensitivity of 90%, but poor specificity. Conclusions: Most alarm features had poor sensitivity and specificity for the diagnosis of colorectal carcinoma, whilst statistical models performed better in terms of sensitivity. Future studies should examine the utility of dark red rectal bleeding and abdominal mass, and concentrate on maximising specificity when validating statistical models.
Composing Web Services through Automatic Reformulation of Service Specifications
Pathak, Jyotishman , Basu, Samik , Honavar, Vasant

Mayo Clinic

2008 IEEE International Conference on Services Computing | August 1, 2008 | Volume: No volume available | Issue: No issue available | Pages: 361-369

10.1109/scc.2008.124 Get It

Crossroads: Two Points of View: RESIDENT WORK HOURS: DISTINGUISHING RESIDENT SERVICE ISSUES FROM EDUCATION AND SAFETY
Watson, James C.

Mayo Clinic

Neurology | July 28, 2008 | Volume: 71 | Issue: 5 | Pages: 375-376

10.1212/01.wnl.0000319720.48058.a6 | PMID 18663184 Get It

The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial
Giannoulis, Manthos G., Shojaee‐Moradie, Fariba , Sönksen, Peter H. , Umpleby, A. Margot , Jackson, Nicola C. , Nair, K. Sreekumaran , Martin, Finbarr C.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 13, 2008 | Volume: 93 | Issue: 8 | Pages: 3066-3074

10.1210/jc.2007-2695 | PMID 18477661 Get It

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/m
Goldstone, Anthony H., Richards, Susan , Tallman, Martin S. , Buck, Georgina , Burnett, Alan K. , Chopra, Raj, Wiernik, Peter H. , Foroni, Letizia, Paietta, Elisabeth , Litzow, Mark R. , Marks, David I. , Durrant, Jill, McMillan, Andrew , Franklin, Ian M., Luger, Selina M. , Ciobanu, Niculae, Rowe, Jacob M. , Lazarus, Hillard M. , Fielding, Adele K. , Franklin, Ian M.

Mayo Clinic

Blood | November 29, 2007 | Volume: 111 | Issue: 4 | Pages: 1827-1833

10.1182/blood-2007-10-116582 | PMID 18048644 Get It

An international collaboration was set up to prospectively evaluate the role of allogeneic transplantation for adults with acute lymphoblastic leukemia (ALL) and compare autologous transplantation with standard chemotherapy. Patients received 2 phases of induction and, if in remission, were assigned to allogeneic transplantation if they had a compatible sibling donor. Other patients were randomized to chemotherapy for 2.5 years versus an autologous transplantation. A donor versus no-donor analysis showed that Philadelphia chromosome–negative patients with a donor had a 5-year improved overall survival (OS), 53% versus 45% (P = .01), and the relapse rate was significantly lower (P ≤ .001). The survival difference was significant in standard-risk patients, but not in high-risk patients with a high nonrelapse mortality rate in the high-risk donor group. Patients randomized to chemotherapy had a higher 5-year OS (46%) than those randomized to autologous transplantation (37%; P = .03). Matched related allogeneic transplantations for ALL in first complete remission provide the most potent antileukemic therapy and considerable survival benefit for standard-risk patients. However, the transplantation-related mortality for high-risk older patients was unacceptably high and abrogated the reduction in relapse risk. There is no evidence that a single autologous transplantation can replace consolidation/maintenance in any risk group. This study is registered at http://clinicaltrials.gov as NCT00002514.
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Haluska, Paul , Shaw, Heather M. , Batzel, Gretchen N., Yin, Donghua, Molina, Julian R. , Molife, L Rhoda, Sharma, Amarnath , Gualberto, Antonio , Adjei, Alex A. , Bono, Johann S. de , Yap, Timothy Anthony , Roberts, Michelle L. , Gualberto, Antonio , de Bono, Johann

Mayo Clinic

Clinical Cancer Research | October 1, 2007 | Volume: 13 | Issue: 19 | Pages: 5834-5840

10.1158/1078-0432.ccr-07-1118 | PMID 17908976 Get It

Abstract Purpose: This phase I study was undertaken to define the maximum tolerated dose, safety, and pharmacokinetic profile of CP-751,871. Experimental Design: Using a rapid dose escalation design, patients with advanced nonhematologic malignancies were treated with CP-751,871 in four dose escalation cohorts. CP-751,871 was administered i.v. on day 1 of each 21-day cycle. Pharmacokinetic evaluation was done in all treatment cohorts during cycles 1 and 4. Results: Twenty-four patients received 110 cycles at four dose levels. The maximum tolerated dose exceeded the maximal feasible dose of 20 mg/kg and, thus, was not identified. Treatment-related toxicities were generally mild. The most common adverse events were hyperglycemia, anorexia, nausea, elevated aspartate aminotransferase, elevated γ-glutamyltransferase, diarrhea, hyperuracemia, and fatigue. At 20 mg/kg, 10 of 15 patients experienced stability of disease. Two of these patients experienced long-term stability. There were no objective responses. Pharmacokinetic analysis revealed a dose-dependent increase in CP-751,871 exposure and ∼2-fold accumulation on repeated dosing in 21-day cycles. Plasma concentrations of CP-751,871 attained were several log-fold greater than the biologically active concentration. Treatment with CP-751,871 increased serum insulin and human growth hormone levels, with modest increases in serum glucose levels. Conclusions: CP-751,871 has a favorable safety profile and was well tolerated when given in continuous cycles. At the maximal feasible dose of 20 mg/kg, there was a moderate accumulation in plasma exposure, and most of the treated patients experienced stability of disease.
Child Sexual Behavior Inventory: Normative, Psychiatric, and Sexual Abuse Comparisons
Friedrich, William N., Fisher, Jennifer, Dittner, Carrie Anne, Acton, Robert G., Berliner, Lucy , Butler, Judy , Damon, Linda, Davies, William Hobart , Gray, Alison J. , Wright, John

Mayo Clinic

Child Maltreatment | March 10, 2007 | Volume: 6 | Issue: 1 | Pages: 37-49

10.1177/1077559501006001004 | PMID 11217169 Get It

A normative sample of 1,114 children was contrasted with a sample of 620 sexually abused children and 577 psychiatric outpatients on the Child Sexual Behavior Inventory (CSBI), a 38-item behavior checklist assessing sexual behavior in children 2 to 12 years old. The CSBI total score and each individual item differed significantly between the three groups after controlling for age, sex, maternal education, and family income. Sexually abused children exhibited a greater frequency of sexual behaviors than either the normative or psychiatric outpatient samples. Test-retest reliability and interitem correlation were satisfactory. Sexual behavior problems were related to other generic behavior problems. This contributed to the reduced discrimination between psychiatric outpatients and sexually abused children when compared to the normative/sexually abused discrimination.
Use of Beef Ultralente for Basal Insulin Delivery: Plasma Insulin Concentrations After Chronic Ultralente Administration in Patients with IDDM
Rizza, R. A., O’Brien, Peter C. , Service, F J

Mayo Clinic

Diabetes Care | March 5, 2007 | Volume: 9 | Issue: 2 | Pages: 120-123

10.2337/diacare.9.2.120 | PMID 3698778 Get It

Ultralente has been used as the basal component of intensive insulin therapy programs. To determine the degree to which a single daily subcutaneous injection of beef ultralente provides stable basal insulin concentrations, plasma free insulin concentrations were measured in six insulin-dependent diabetic patients over a 40-h period. All short-acting insulin was withheld during this interval. Each patient had been maintained on a chronic ultralente based program before study. Little if any evidence of a temporal peak in plasma insulin concentrations was observed. Although considerable variation in plasma insulin concentrations was observed in one individual, beef ultralente provided relatively stable plasma insulin concentrations in the group as a whole. Beef ultralente appears to be a reasonable insulin preparation to use as the basal component in an intensive insulin therapy program.
Pancreatic Polypeptide: A Marker for Lean Non-insulin-dependent Diabetes Mellitus?
Service, F. John, KOCH, MARK B., Jay, Joan M, Rizza, Robert A., Go, Vay Liang W.

Mayo Clinic

Diabetes Care | March 5, 2007 | Volume: 8 | Issue: 4 | Pages: 349-353

10.2337/diacare.8.4.349 | PMID 4042801 Get It

Both basal and postprandial pancreatic polypeptide (PP) concentrations were exaggerated twofold in lean NIDDM patients, whereas they were normal in lean IDDM and obese NIDDM patients who were hyperglycemic as a result of partial insulin withdrawal. Insulin infusion from an artificial endocrine pancreas, which resulted in fasting euglycemia and near-normoglycemia postprandially, had no effect on PP responses in any of the diabetic patients. No postprandial PP responses were observed in totally pancreatectomized (TPX) patients. Excessive basal and postprandial concentrations of PP in diabetes appear to be related to both leanness and residual beta cell function and, therefore, potential markers for lean NIDDM.